X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1449) 1449
Publication (120) 120
Book Review (7) 7
Book Chapter (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (814) 814
phenylenediamines - pharmacology (729) 729
humans (469) 469
index medicus (450) 450
male (427) 427
rats (422) 422
pharmacology & pharmacy (255) 255
female (234) 234
mice (214) 214
carbamates - pharmacology (200) 200
toxicology (177) 177
dose-response relationship, drug (171) 171
biochemistry & molecular biology (159) 159
phenylenediamines - metabolism (147) 147
phenylenediamines - chemistry (128) 128
cells, cultured (119) 119
antioxidants - pharmacology (118) 118
phenylenediamines - toxicity (117) 117
oxidation-reduction (116) 116
time factors (112) 112
phenylenediamines - therapeutic use (111) 111
retigabine (110) 110
kinetics (108) 108
anticonvulsants - pharmacology (105) 105
in vitro techniques (103) 103
phenylenediamines (93) 93
potassium channels (90) 90
activation (89) 89
neurosciences (89) 89
chemistry, medicinal (83) 83
rats, sprague-dawley (82) 82
anticonvulsant retigabine (81) 81
epilepsy (81) 81
rats, inbred strains (78) 78
rats, wistar (74) 74
cell line (73) 73
cell survival - drug effects (72) 72
analysis (70) 70
adult (68) 68
p-phenylenediamine (68) 68
phenylenediamine (68) 68
mutagenicity tests (66) 66
liver - drug effects (65) 65
oxidative stress (65) 65
salmonella typhimurium - drug effects (64) 64
in-vitro (63) 63
liver - metabolism (63) 63
cancer (62) 62
cell biology (62) 62
carbamates - therapeutic use (61) 61
cell line, tumor (60) 60
o-phenylenediamine (59) 59
cells (58) 58
mutation (58) 58
phenylenediamines - adverse effects (58) 58
anthracenes - pharmacology (57) 57
structure-activity relationship (57) 57
disease models, animal (56) 56
expression (55) 55
phenylenediamines - administration & dosage (55) 55
anticonvulsants (54) 54
phenylenediamines - pharmacokinetics (52) 52
anticonvulsants - therapeutic use (51) 51
inhibition (50) 50
potassium channel blockers - pharmacology (50) 50
drug interactions (49) 49
hydrogen-ion concentration (49) 49
seizures (49) 49
mice, inbred c57bl (48) 48
pyridines - pharmacology (48) 48
research (48) 48
biotransformation (47) 47
kcnq potassium channels - metabolism (47) 47
molecular structure (47) 47
article (46) 46
cricetinae (46) 46
mutagens (46) 46
antioxidants (44) 44
metabolism (44) 44
neurons - drug effects (44) 44
toxicity (44) 44
apoptosis (43) 43
lipid peroxidation - drug effects (43) 43
microsomes, liver - metabolism (43) 43
pharmacology (43) 43
chemistry, multidisciplinary (42) 42
kcnq (42) 42
middle aged (42) 42
indoles - pharmacology (41) 41
para-phenylenediamine (41) 41
patch-clamp techniques (41) 41
antineoplastic agents - pharmacology (40) 40
derivatives (40) 40
neurons (40) 40
biophysics (39) 39
enzyme inhibitors - pharmacology (39) 39
reactive oxygen species - metabolism (38) 38
ascorbic acid - pharmacology (37) 37
cattle (37) 37
chemistry (37) 37
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1391) 1391
Japanese (18) 18
Russian (14) 14
German (9) 9
Chinese (7) 7
French (4) 4
Polish (3) 3
Italian (2) 2
Croatian (1) 1
Hungarian (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 03/2014, Volume 306, Issue 6, pp. L476 - L486
Journal Article
Brain Research, ISSN 0006-8993, 2010, Volume 1339, pp. 26 - 40
Journal Article
Cancer Cell, ISSN 1535-6108, 05/2017, Volume 31, Issue 5, pp. 635 - 652.e6
Diffuse intrinsic pontine glioma (DIPG) is a fatal pediatric cancer with limited therapeutic options. The majority of cases of DIPG exhibit a mutation in... 
oligodendrocyte precursor cell | CDK7 | potassium channel | DIPG | EPH | super-enhancer | BRD4 | THERAPEUTIC STRATEGY | SUPER-ENHANCERS | GENE | ONCOLOGY | CELL IDENTITY | K27M MUTATION | C-MYC | HISTONE H3.3 | BET BROMODOMAIN INHIBITION | MYC EXPRESSION | TUMOR-GROWTH | CELL BIOLOGY | Transcription, Genetic - drug effects | Cyclin-Dependent Kinases - metabolism | Humans | Drug Resistance, Neoplasm | Male | Brain Stem Neoplasms - drug therapy | Glioma - genetics | RNA Interference | Time Factors | Glioma - pathology | Receptors, Eph Family - metabolism | Cyclin-Dependent Kinases - antagonists & inhibitors | Receptors, Eph Family - genetics | Pyrimidines - pharmacology | Drug Synergism | Signal Transduction - drug effects | Histone Deacetylase Inhibitors - pharmacology | Mice, Inbred NOD | Phenylenediamines - pharmacology | Histones - metabolism | Mutation | Glioma - drug therapy | Brain Stem Neoplasms - pathology | Brain Stem Neoplasms - metabolism | Chromatin Assembly and Disassembly - drug effects | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Glioma - metabolism | Dose-Response Relationship, Drug | Transfection | Female | Indoles - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Cyclin-Dependent Kinases - genetics | Nuclear Proteins - genetics | Hydroxamic Acids - pharmacology | Nuclear Proteins - metabolism | Transcription Factors - antagonists & inhibitors | Transcription Factors - genetics | Mice, SCID | Azepines - pharmacology | Transcription Factors - metabolism | Triazoles - pharmacology | Xenograft Model Antitumor Assays | Animals | Brain Stem Neoplasms - genetics | Histones - genetics | Nuclear Proteins - antagonists & inhibitors | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Primary Cell Culture | Medical colleges | Gliomas | Developmental biology | Stem cells | Genetic aspects | Genetic transcription | Cell differentiation | Chromatin | Analysis | Potassium channels | Cells
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 09/2017, Volume 140, pp. 41 - 52
Ferroptosis has recently been identified as a mode of programmed cell death. However, little is yet known about the signaling mechanism. Here, we report that... 
Acute leukemia | Redox | Ferroptosis | Cell death | ROS | APOPTOSIS | OXIDATIVE STRESS | ACTIVATION | NECROPTOSIS | 5-LIPOXYGENASE INHIBITOR | ARACHIDONIC-ACID | PEROXIDATION | ZILEUTON | ANTIOXIDANT | RESISTANCE | PHARMACOLOGY & PHARMACY | Masoprocol - pharmacology | Reactive Oxygen Species - metabolism | Arachidonate 12-Lipoxygenase - metabolism | Glutathione Peroxidase - antagonists & inhibitors | Humans | Arachidonate 12-Lipoxygenase - chemistry | Arachidonate 15-Lipoxygenase - chemistry | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Cyclohexylamines - pharmacology | Lipid Peroxidation - drug effects | Antineoplastic Agents - pharmacology | Cell Death - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Neoplasm Proteins - genetics | alpha-Tocopherol - pharmacology | Arachidonate 12-Lipoxygenase - genetics | Fas-Associated Death Domain Protein - genetics | Glutathione Peroxidase - metabolism | Flavanones - pharmacology | Fas-Associated Death Domain Protein - metabolism | Carbolines - antagonists & inhibitors | Antioxidants - pharmacology | Antineoplastic Agents - chemistry | Arachidonate 15-Lipoxygenase - metabolism | Glutathione Peroxidase - genetics | Reactive Oxygen Species - antagonists & inhibitors | Arachidonate 15-Lipoxygenase - genetics | Cell Line, Tumor | Precursor Cell Lymphoblastic Leukemia-Lymphoma - enzymology | Phenylenediamines - pharmacology | Kinetics | Oxidative Stress - drug effects | Lipoxygenase Inhibitors - pharmacology | Carbolines - pharmacology | Biochemistry | Peroxidase | Acute lymphocytic leukemia | Index Medicus
Journal Article
Journal Article
Neuroscience Letters, ISSN 0304-3940, 01/2003, Volume 335, Issue 3, pp. 167 - 170
Some anticonvulsants show neuroprotective effects, and may be of use in reducing neuronal death resulting from stroke or traumatic brain injury. Here I report... 
Oxygen/glucose deprivation | Hippocampal slice cultures | Neuroprotection | Anticonvulsants | OXYGEN | INHIBITION | IN-VITRO ISCHEMIA | neuroprotection | DRUGS | hippocampal slice cultures | oxygen/glucose deprivation | GLUCOSE DEPRIVATION | anticonvulsants | NEUROSCIENCES | DAMAGE | Phenobarbital - pharmacology | Hypoxia - drug therapy | Amines | Felbamate | Gabapentin | Rats, Wistar | Phenylcarbamates | Anticonvulsants - administration & dosage | Hippocampus - drug effects | Anticonvulsants - pharmacology | Valproic Acid - pharmacology | Hypoxia - metabolism | Dose-Response Relationship, Drug | Oxcarbazepine | Tiagabine | Neuroprotective Agents - pharmacology | Piracetam - pharmacology | Phenytoin - pharmacology | Chlordiazepoxide - pharmacology | Neurons - metabolism | Cell Death - drug effects | Neurons - drug effects | Neuroprotective Agents - administration & dosage | Nipecotic Acids - pharmacology | Carbamates - pharmacology | Propylene Glycols - pharmacology | gamma-Aminobutyric Acid | Carbamazepine - pharmacology | Triazines - pharmacology | Carbamazepine - analogs & derivatives | Cells, Cultured | Ischemia - metabolism | Rats | Hippocampus - cytology | Glucose - deficiency | Hippocampus - metabolism | Animals | Ischemia - drug therapy | Piracetam - analogs & derivatives | Phenylenediamines - pharmacology | Acetates - pharmacology | Cyclohexanecarboxylic Acids | Ethosuximide - pharmacology | Midazolam - pharmacology | Lamotrigine | Levetiracetam | Brain | Cell death | Injuries | Stroke (Disease)
Journal Article
Cell death & disease, ISSN 2041-4889, 07/2016, Volume 7, Issue 7, pp. e2307 - e2307
Journal Article
Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 01/2012, Volume 302, Issue 1, pp. 120 - 132
Expression and function of Kv7 (KCNQ) voltage-activated potassium channels in guinea pig and human airway smooth muscle cells (ASMCs) were investigated by... 
Kcnq voltage-activated potassium channel | Asthma therapy | Bronchoconstrictor signal transduction | Precision-cut lung slice | PROTEIN-KINASE-C | PHYSIOLOGY | RAT | bronchoconstrictor signal transduction | FUNCTIONAL-CHARACTERIZATION | GUINEA-PIG | KCNQ voltage-activated potassium channel | RESPIRATORY SYSTEM | asthma therapy | precision-cut lung slice | KCNQ | ASTHMA | IONIC MECHANISMS | ARTERY | EXPRESSION | CLINICAL-SIGNIFICANCE | Humans | Male | Bronchodilator Agents - metabolism | Bronchoconstriction - drug effects | Methacholine Chloride - pharmacology | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - metabolism | Carbamates - pharmacology | Pyrazoles - pharmacology | Bronchoconstriction - physiology | Guinea Pigs | Histamine - pharmacology | Bronchodilator Agents - pharmacology | Celecoxib | Calcium Channel Blockers - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Sulfonamides - pharmacology | Verapamil - pharmacology | Anthracenes - pharmacology | KCNQ Potassium Channels - drug effects | Patch-Clamp Techniques | Animals | Signal Transduction - drug effects | KCNQ Potassium Channels - metabolism | Aminopyridines - pharmacology | Phenylenediamines - pharmacology | KCNQ Potassium Channels - genetics | Physiological aspects | Muscle cells | Cellular signal transduction | Potassium channels | Research | Health aspects | Bronchodilator agents
Journal Article
Journal of Cardiovascular Pharmacology, ISSN 0160-2446, 01/2013, Volume 61, Issue 1, pp. 51 - 62
Cerebral vasospasm after subarachnoid hemorrhage (SAH) is characterized by prolonged severe constriction of the basilar artery, which often leads to ischemic... 
basilar artery | potassium channel | retigabine | celecoxib | cerebral vasospasm | membrane depolarization | RABBIT BASILAR ARTERY | PULMONARY | PROTEIN-KINASE-C | CARDIAC & CARDIOVASCULAR SYSTEMS | CONSTRICTOR RESPONSES | ANEURYSMAL SUBARACHNOID HEMORRHAGE | DEPENDENT K+ CHANNELS | MILD HYPOTHERMIA | MECHANISMS | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | Myography | Muscle, Smooth, Vascular - metabolism | Endothelin-1 - pharmacology | Basilar Artery - metabolism | Male | Serotonin - pharmacology | Muscle, Smooth, Vascular - physiopathology | KCNQ Potassium Channels - antagonists & inhibitors | Vasospasm, Intracranial - prevention & control | Basilar Artery - physiopathology | Time Factors | Membrane Transport Modulators - pharmacology | Vasospasm, Intracranial - metabolism | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - metabolism | Potassium Channel Blockers - pharmacology | Subarachnoid Hemorrhage - drug therapy | Carbamates - pharmacology | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | Pyrazoles - pharmacology | Vasoconstrictor Agents - pharmacology | Vasospasm, Intracranial - etiology | Basilar Artery - drug effects | KCNQ Potassium Channels - agonists | Rats | Subarachnoid Hemorrhage - complications | Celecoxib | Arginine Vasopressin - pharmacology | Sulfonamides - pharmacology | Rats, Sprague-Dawley | Vasoconstriction - drug effects | Anthracenes - pharmacology | Subarachnoid Hemorrhage - metabolism | Patch-Clamp Techniques | Subarachnoid Hemorrhage - physiopathology | Animals | Signal Transduction - drug effects | Vasospasm, Intracranial - physiopathology | KCNQ Potassium Channels - metabolism | Phenylenediamines - pharmacology
Journal Article
BRITISH JOURNAL OF PHARMACOLOGY, ISSN 0007-1188, 07/2007, Volume 151, Issue 6, pp. 758 - 770
Journal Article
Journal Article